These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15995060)

  • 1. Pediatricians and antidepressant medications: black box or black hole?
    Wegner LM
    Pediatrics; 2005 Jul; 116(1):233-5. PubMed ID: 15995060
    [No Abstract]   [Full Text] [Related]  

  • 2. Thinking outside the (black) box: antidepressants, suicidality, and research synthesis.
    Greenhouse JB; Kelleher KJ
    Pediatrics; 2005 Jul; 116(1):231-3. PubMed ID: 15995059
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M; Marcus SC; Druss BG
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.
    Olfson M; Marcus SC; Shaffer D
    Arch Gen Psychiatry; 2006 Aug; 63(8):865-72. PubMed ID: 16894062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology. Study questions antidepressant risks.
    Couzin J
    Science; 2007 Apr; 316(5823):354. PubMed ID: 17446361
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: opening Pandora's suicide box.
    Lineberry TW; Bostwick JM; Beebe TJ; Decker PA
    Mayo Clin Proc; 2007 Apr; 82(4):518-20. PubMed ID: 17418083
    [No Abstract]   [Full Text] [Related]  

  • 7. Suicidality in adolescents being treated with antidepressant medications and the black box label: position paper of the Society for Adolescent Medicine.
    Lock J; Walker LR; Rickert VI; Katzman DK;
    J Adolesc Health; 2005 Jan; 36(1):92-3. PubMed ID: 15702497
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric primary care providers and adolescent depression: a qualitative study of barriers to treatment and the effect of the black box warning.
    Richardson LP; Lewis CW; Casey-Goldstein M; McCauley E; Katon W
    J Adolesc Health; 2007 May; 40(5):433-9. PubMed ID: 17448401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating pediatric depression in primary care: coping with the patients' blue mood and the FDA's black box.
    Rappaport N; Bostic JQ; Prince JB; Jellinek M
    J Pediatr; 2006 May; 148(5):567-8. PubMed ID: 16737859
    [No Abstract]   [Full Text] [Related]  

  • 10. The antidepressant quandary--considering suicide risk when treating adolescent depression.
    Simon GE
    N Engl J Med; 2006 Dec; 355(26):2722-3. PubMed ID: 17192536
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E; Allen PJ
    Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. British panel bans use of antidepressant to treat children.
    Abbott A
    Nature; 2003 Jun; 423(6942):792. PubMed ID: 12815392
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidepressant use in the absence of common mental disorders in the general population.
    Pagura J; Katz LY; Mojtabai R; Druss BG; Cox B; Sareen J
    J Clin Psychiatry; 2011 Apr; 72(4):494-501. PubMed ID: 21294990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicide-related events among child and adolescent patients during short-term antidepressant therapy.
    Kuba T; Yakushi T; Fukuhara H; Nakamoto Y; Singeo ST; Tanaka O; Kondo T
    Psychiatry Clin Neurosci; 2011 Apr; 65(3):239-45. PubMed ID: 21507130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international perspective on pediatric psychopharmacology.
    Vitiello B
    Int Rev Psychiatry; 2008 Apr; 20(2):121-6. PubMed ID: 18386201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The medication solution: tapering down.
    Jackim LW
    Behav Healthc Tomorrow; 2004 Dec; 13(6):15-9. PubMed ID: 15700612
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the pediatrician and the health-mental health delivery of care system in the United States.
    Silver LB
    J Dev Behav Pediatr; 1982 Dec; 3(4):217-24. PubMed ID: 7153367
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of culture, government and the law on the use of antidepressants for children in the United States and Pakistan.
    Termini RB; Kelly-Miller CA
    Food Drug Law J; 2008; 63(3):713-21. PubMed ID: 19031670
    [No Abstract]   [Full Text] [Related]  

  • 20. The risks and benefits of antidepressant treatment for youth depression.
    Bridge JA; Salary CB; Birmaher B; Asare AG; Brent DA
    Ann Med; 2005; 37(6):404-12. PubMed ID: 16203613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.